Yijiang Shi

Internal Medicine

450 Stanyan St
San Francisco, CA 94117

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Editorial Expression of Concern: Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.

Editorial Expression of Concern: Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.

Journal: Oncogene

Published: August 10, 2026

Retraction: A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.

Retraction: A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.

Journal: Molecular cancer therapeutics

Published: July 02, 2026

Retraction: Mammalian Target of Rapamycin Inhibitors Activate the AKT Kinase in Multiple Myeloma Cells by Up-regulating the Insulin-like Growth Factor Receptor/Insulin Receptor Substrate-1/Phosphatidylinositol 3-Kinase Cascade.

Retraction: Mammalian Target of Rapamycin Inhibitors Activate the AKT Kinase in Multiple Myeloma Cells by Up-regulating the Insulin-like Growth Factor Receptor/Insulin Receptor Substrate-1/Phosphatidylinositol 3-Kinase Cascade.

Journal: Molecular cancer therapeutics

Published: July 02, 2026

Retraction: Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.

Retraction: Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.

Journal: Cancer research

Published: May 08, 2026

Retraction: SGK Kinase Activity in Multiple Myeloma Cells Protects against ER Stress Apoptosis via a SEK-Dependent Mechanism.

Retraction: SGK Kinase Activity in Multiple Myeloma Cells Protects against ER Stress Apoptosis via a SEK-Dependent Mechanism.

Journal: Molecular cancer research : MCR

Published: March 31, 2026

Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.

Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.

Journal: Biomolecules

Published: March 28, 2023

Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation.

Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation.

Journal: The Journal of biological chemistry

Published: October 01, 2021

Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.

Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.

Journal: Molecular cancer therapeutics

Published: January 06, 2021

A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.

A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.

Journal: Molecular cancer therapeutics

Published: January 31, 2019

Structure-activity relationship study of small molecule inhibitors of the DEPTOR-mTOR interaction.

Structure-activity relationship study of small molecule inhibitors of the DEPTOR-mTOR interaction.

Journal: Bioorganic & medicinal chemistry letters

Published: May 18, 2017

RETRACTED: Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.

RETRACTED: Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.

Journal: Cancer research

Published: April 12, 2016

RETRACTED: SGK Kinase Activity in Multiple Myeloma Cells Protects against ER Stress Apoptosis via a SEK-Dependent Mechanism.

RETRACTED: SGK Kinase Activity in Multiple Myeloma Cells Protects against ER Stress Apoptosis via a SEK-Dependent Mechanism.

Journal: Molecular cancer research : MCR

Published: October 15, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026